Surabhi Dangi-Garimella, AJMC.com
Articles
Comparing CVD Risk Factors Associated With Adjuvant Endocrine Therapies
May 02, 2016
Article
A retrospective analysis conducted by researchers at Kaiser Permanente and UCLA has concluded that patients with breast cancer treated with aromatase inhibitors (AIs) as adjuvant endocrine therapy were at equal risk of serious cardiovascular disease (CVD) events as those treated with tamoxifen.
Families Have Distinct Preferences for End-of-Life Care
March 10, 2016
Article
The results of this study underscore the importance of advance care planning in improving the quality of care that patients receive at end-of-life.
Advertisement
Advertisement